EW vs FIG · P/E 47, rev $1.39B vs rev $274.2M
Edwards Lifesciences Corp (EW) versus Figma, Inc. (FIG) — a side-by-side from cached financials, not a winner call.
Edwards Lifesciences Corp (EW) is a medical devices company listed on NYSE.
Figma, Inc. (FIG) is a software - application company listed on NYSE.
Latest reported EW revenue for 2024-12-31 was $1.39B. Net income was $385.6M. Revenue was up 2.3% from 2024-09-30 to 2024-12-31. EW currently screens at market cap $49.91B and trailing P/E 46.9.
Latest reported FIG revenue for 2025-09-30 was $274.2M. Net income was -$1.10B. Revenue was up 9.8% from 2025-06-30 to 2025-09-30. FIG currently screens at market cap $9.56B.
EW currently screens at market cap $49.91B and trailing P/E 46.9. FIG currently screens at market cap $9.56B.
Not investment advice. Open the EW and FIG stock pages for the full models.
Not investment advice.